The MICs of 16 antimicrobial agents were determined for 202 Campylobacter jejuni isolates, 123 Campylobacter coli isolates, and 6 Campylobacter lari isolates from humans and food animals in Denmark. The C. jejuni isolates originated from humans (75), broilers (95), cattle (29), and pigs (3); the C. coli isolates originated from humans (7), broilers (17), and pigs (99); and the C. lari isolates originated from broilers (5) and cattle (1). All isolates were susceptible to apramycin, neomycin, and gentamicin. Only a few C. jejuni isolates were resistant to one or more antimicrobial agents. Resistance to tetracycline was more common among C. jejuni isolates from humans (11%) than among C. jejuni isolates from animals (0 to 2%). More resistance to streptomycin was found among C. jejuni isolates from cattle (10%) than among those from humans (4%) or broilers (1%). A greater proportion of C. coli than of C. jejuni isolates were resistant to the other antimicrobial agents tested. Isolates were in most cases either coresistant to tylosin, spiramycin, and erythromycin or susceptible to all three antibiotics. More macrolide-resistant isolates were observed among C. coli isolates from swine (79%) than among C. coli isolates from broilers (18%) and humans (14%). Twenty-four percent of C. coli isolates from pigs were resistant to enrofloxacin, whereas 29% of C. coli isolates from humans and none from broilers were resistant. More resistance to streptomycin was observed among C. coli isolates from swine (48%) than among C. coli isolates from broilers (6%) or humans (0%). The six C. lari isolates were susceptible to all antimicrobial agents except ampicillin and nalidixic acid. This study showed that antimicrobial resistance was found only at relatively low frequencies among C. jejuni and C. lari isolates. Among C. coli isolates, especially from swine, there was a high level of resistance to macrolides and streptomycin. Furthermore, this study showed differences in the resistance to antimicrobial agents among Campylobacter isolates of different origins.
to know whether antimicrobial-resistant Campylobacter can be isolated from animals and whether these bacteria can be transferred to man.
This study was conducted to compare the frequency of isolation and the occurrence of antimicrobial resistance among different thermophilic Campylobacter spp. isolated in clinical infections in humans and from feces of healthy food animals in Denmark.
MATERIALS AND METHODS

Bacterial isolates.
A total of 82 human clinical isolates, 102 isolates from swine, 30 isolates from cattle, and 117 isolates from broilers were included in the study. Isolates from humans originated from clinical cases of diarrhea submitted to Statens Serum Institut for clinical examination. Isolates from food animals originated from fecal samples taken at slaughter from healthy animals and submitted to the Danish Veterinary Laboratory as part of a newly established surveillance scheme for antimicrobial resistance in Denmark. Only one isolate per herd or broiler flock was included in the study. All isolates were collected during 1995 and 1996. Thermophilic Campylobacter spp. were isolated from fecal samples of swine and cattle by selective enrichment in Preston broth (4) and incubated for 18 to 24 h at 42°C in a microaerobic atmosphere (approximately 6% O 2 , 7% CO 2 , 7% H 2 , 80% N 2 ) that was created by a gas evacuation procedure (16) . One loopful (10 l) of the broth was transferred to mCCDA (Oxoid CM739 plus selective supplement SR155E). Cloacal swabs from broilers were streaked directly onto mCCDA. Agar plates were incubated at 42°C for 2 to 4 days in a microaerobic atmosphere. One isolate from each sample was identified to species level on the basis of phase-contrast microscopy (characteristic morphology and mobility), catalase, oxidase, indoxyl acetate hydrolysis, hippurate hydrolysis, and susceptibility to nalidixic acid and cephalothin (2) . Only isolates identified as C. jejuni, C. coli, or Campylobacter lari were tested for susceptibility.
MIC determinations.
The following antimicrobial agents were tested: ampicillin, apramycin, carbadox, chloramphenicol, colistin, enrofloxacin, erythromycin, gentamicin, nalidixic acid, neomycin, olaquindox, spectinomycin, spiramycin, streptomycin, tetracycline, and tylosin. The dilution ranges used for these anti-microbial agents were as follows: for ampicillin, apramycin, chloramphenicol, enrofloxacin, erythromycin, gentamicin, spectinomycin, and tetracycline, 0.25 to 32 g/ml; for carbadox and olaquindox, 0.06 to 128 g/ml; for colistin, 0.125 to 256 g/ml; for nalidixic acid and streptomycin, 1 to 128 g/ml; for neomycin, 0.5 to 64 g/ml; and for tylosin, 0.5 to 128 g/ml. MIC determinations were performed by the agar dilution method with Mueller-Hinton II agar (Becton Dickinson Microbiology Systems, Cockeysville, Md.) supplemented with 5% bovine blood. All MIC plates were inoculated with approximately 10 4 CFU by following the procedure of Tenover et al. (26) . The plates were incubated for 48 h at 37°C in a microaerobic atmosphere (approximately 6% O 2 , 7% CO 2 , 7% H 2 , 80% N 2 ). The MIC was defined as the lowest concentration producing no visible growth. The following National Committee for Clinical Laboratory Standards breakpoints for resistance (14, 15) were used: for ampicillin, chloramphenicol, and nalidixic acid, Ն32 g/ml; for enrofloxacin, Ն2 g/ml; for erythromycin, Ն8 g/ml; for gentamicin, Ն16 g/ml; and for tetracycline, Ն16 g/ml. For the aminoglycosides apramycin, neomycin, and streptomycin, the breakpoint for gentamicin was used; for spiramycin, the breakpoint for erythromycin was used; and for spectinomycin, the breakpoint for netilmicin (Ն32 g/ml) was used. No internationally accepted breakpoints for resistance to colistin, carbadox, and olaquindox are available. For tylosin, a breakpoint of Ն64 g/ml was used.
The following quality control strains were included on each agar plate: Staphylococcus aureus ATCC 25927, Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27852, and Enterococcus faecalis ATCC 29212.
RESULTS AND DISCUSSION
The development of antimicrobial resistance in pathogenic bacteria is a matter of increasing concern. The thermophilic Campylobacter species C. jejuni, C. coli, and C. lari can be isolated from different animal sources and may be transferred from animals to humans. Thus, the development of antimicrobial resistance in these Campylobacter spp., due to the use of antimicrobial agents in food animals, may have consequences for the treatment of infections in humans. Furthermore, these bacteria are frequently found in different animal sources, and they may therefore be a good choice as indicator organisms for monitoring the development of antimicrobial resistance among different animal sources.
In the present study 75 isolates from humans, 29 isolates from cattle, 95 isolates from broilers, and 3 isolates from pigs were identified as C. jejuni. Seven isolates from humans, 99 isolates from pigs, and 17 isolates from broilers were identified as C. coli, and 5 isolates from broilers and 1 isolate from cattle were identified as C. lari. These observations are in general agreement with those of previous studies (6, 9, 18, 19, 30) and indicate differences in the frequency of different Campylobacter species among the different animal sources.
MICs, MICs at which 50% of the isolates are inhibited (MIC 50 s), MIC 90 s, and percent resistant isolates are shown in Tables 1 and 2 . No internationally accepted criteria for susceptibility testing or for breakpoints for susceptible versus resistant isolates are available for Campylobacter spp. For therapeutic agents, the breakpoints established for aerobic bacteria were used (14, 15) . Tylosin has low activity under microaerophilic conditions, so a breakpoint of 64 g/ml was used. For colistin, carbadox, and olaquindox, no breakpoints are available.
All C. jejuni isolates were susceptible to the aminoglycosides apramycin, neomycin, and gentamicin (Table 1) . Only a limited number of C. jejuni isolates tested resistant to one or more antimicrobial agents. Isolates were in most cases either simultaneously resistant to the macrolide antibiotics tylosin, spiramycin, and erythromycin or susceptible to all three macrolides. However, only 7 (7%) of 95 isolates from broilers, 1 (3%) of 29 isolates from cattle, and 1 of the 3 isolates from pigs were resistant to erythromycin. This is in general agreement with the findings of previous studies among animals (5, 6, 24, 27, 29) and among humans in other countries (1, 12, 18, 19, (22) (23) (24) 29) .
Resistance to tetracycline was more common among C. jejuni isolates from humans (11%) than among C. jejuni isolates from animals (0 to 2%). A previous Danish study found all isolates susceptible to tetracycline (1), whereas studies from other countries have reported relatively high levels of resistance to tetracycline (12, 18-20, 23, 30) . This could indicate some development in resistance to tetracycline among Danish human clinical isolates during the past 10 years.
More resistance to streptomycin was observed among C. jejuni isolates from cattle (10%) than among those from humans (4%) or broilers (1%). One of the three isolates from pigs also tested resistant to streptomycin. Relatively high levels of resistance to streptomycin among isolates from cattle have also been reported in other studies (5, 6, 27) .
Increased resistance to fluoroquinolones was first reported for Campylobacter from chickens (7), and Jacobs-Reitsma et al. (10) reported almost 30% fluoroquinolone resistance among Campylobacter isolates from broilers in the Netherlands. Among isolates from humans, resistance to fluoroquinolones among C. jejuni isolates has emerged as a significant problem in several countries in recent years (7, 18, 19, 20, 29) . However, in Sweden the level of resistance has constantly remained low (23) . In the present study 9% of human clinical isolates, 7% of isolates from cattle, 14% of isolates from broilers, and one of three isolates from pigs were resistant to the fluoroquinolone enrofloxacin. This indicates that resistance to fluoroquinolones has not at present emerged as a significant problem in Denmark.
Carbadox and olaquindox are two antimicrobial agents used for growth promotion in Denmark. No breakpoints for susceptibility versus resistance are available, and no data on the susceptibility of Campylobacter to these agents have previously been reported. In general, carbadox showed very good activity against C. jejuni, with a MIC 90 from Յ0.06 to 2 g/ml. However, the MIC for two isolates from humans was 32 g/ml.
Isolates could be divided into two groups, with a breakpoint of 1 g/ml (Table 2) . Olaquindox was less active than carbadox, with a MIC 90 from 2 to 4 g/ml.
MICs of ampicillin were close to the breakpoint. More resistance was observed among C. jejuni isolates from humans than among isolates from the other animal species.
When the occurrence of resistance among C. jejuni isolates from the different sources was compared, the same low levels of resistance to most antimicrobial agents were observed. However, resistance to streptomycin was more frequent among C. jejuni isolates from cattle and resistance to tetracycline was more frequent among isolates from humans. Thus, even though the level of resistance in general was low, this indicated some differences in the susceptibility pattern among C. jejuni isolates of different origin.
More resistance was observed among isolates of C. coli than among isolates of C. jejuni. As with C. jejuni, all C. coli isolates were susceptible to the aminoglycosides apramycin, neomycin, and gentamicin (Table 1) . Whereas most C. jejuni isolates were susceptible to erythromycin and the other antibiotics of the macrolide group, 1 of 7 C. coli isolates from humans (14%), 3 of 17 from broilers (18%), and most isolates from pigs (79%) were resistant to erythromycin. High levels of resistance to macrolides among C. coli isolates have also been reported in other studies (6, 9, 11, 20, 22, 28, 30) . Since tylosin is widely used as a growth promoter in Denmark, the high level of macrolide resistance among isolates from pigs could be due to this selective pressure.
As also reported by Cabrita et al. (6) , only a few C. coli isolates were resistant to tetracycline; however, this is in contrast to observations by other authors (5, 11, 20, 29) . A high proportion (48%) of C. coli isolates from pigs were resistant to streptomycin, which is in agreement with previous studies (5, 6, 11), whereas only a few isolates from broilers (6%) and none from humans were resistant. Two of seven isolates from humans tested resistant to enrofloxacin, whereas no isolates from broilers and 24% of the C. coli isolates from pigs tested resistant. In general, the levels of resistance to fluoroquinolones among C. coli isolates were higher than those for C. jejuni.
As with C. jejuni, carbadox showed good activity against C. coli, with a MIC 90 from 0.25 to 4 g/ml. The MIC 90 of olaquindox ranged from 2 to 4 g/ml, and MICs of ampicillin were close to the breakpoint.
When the occurrence of antimicrobial resistance among C. coli isolates from the different sources was compared, differences in the resistance to macrolides, enrofloxacin, and streptomycin were apparent. However, the limited number of C. coli isolates from broilers and humans makes comparison difficult.
Only six C. lari isolates were recovered among the isolates examined in the present study. These isolates were susceptible to all antimicrobial agents tested, except for two isolates that were resistant to ampicillin and four that were resistant to nalidixic acid. Considering the limited number of isolates, it is not possible to compare levels of resistance between C. lari and the other Campylobacter species or among isolates from different animal sources.
When the antimicrobial susceptibilities for the Campylobacter isolates from the different sources were compared, some differences in the pattern of antimicrobial resistance among isolates were observed. C. jejuni was predominant among isolates from humans, cattle, and broilers but was not recovered from pigs. C. coli was predominant among isolates from pigs and was recovered from humans and broilers but not from cattle, whereas C. lari isolates were recovered in small numbers from broilers and cattle. For C. jejuni, more resistance to tetracycline was observed among isolates from humans than among isolates from the different animals and more resistance to streptomycin was observed among isolates from cattle than among isolates from humans and broilers. For C. coli, more resistance to streptomycin and macrolides was found among isolates from pigs than among isolates from humans and broilers. Thus, for both C. jejuni and C. coli, no obvious correlation between the resistance patterns of Campylobacter isolates of the same species from the different animal sources and humans could be observed. This could indicate that in Denmark there are other sources than food animals for Campylobacter infections in humans. Furthermore, the generally low level of antimicrobial resistance among isolates from humans suggests that at present, resistance is not to a large degree transferred to or developing in Campylobacter isolates causing infections in humans. However, the occurrence of antimicrobial resistance genes among bacterial isolates capable of infecting humans is a matter of great concern, and the possibility that resistant bacteria or resistance genes may be transferred from animals to humans should be studied very closely. It is therefore necessary to continuously monitor the development of antimicrobial resistance.
The differences in isolation rate of the different Campylobacter species among the different sources may make it difficult to compare levels of resistance between the sources. Thus, it is at present difficult to say whether the higher level of macrolide resistance among C. coli isolates is because of their origin (most isolates are from pigs) or is related to true differences among the species. The higher level of macrolide resistance among C. coli isolates from humans and broilers than among C. jejuni isolates from the same origins indicates that there is a true difference in the ability of these species to become macrolide resistant. The possibility of isolating C. jejuni from humans, broilers, pigs, and cattle, and the initially low level of resistance among isolates from these sources, makes C. jejuni a good candidate for an indicator organism for monitoring the development of antimicrobial resistance among different sources. However, since only a few C. jejuni isolates were recovered from pigs, in which C. coli predominated, it may be difficult to compare levels of resistance among isolates from pigs with those among isolates from broilers, humans, and cattle. Thus, in order to get an acceptable prediction of resistance developing among different animal sources, it will be necessary to include more than one bacterial species.
In conclusion, this study showed that antimicrobial resistance is found only at relatively low frequencies among C. jejuni and C. lari isolates. Among C. coli isolates, especially from swine, there is a high level of resistance to macrolides and streptomycin. Furthermore, this study showed that, for comparison of the levels of resistance of bacterial isolates from different sources, it is important that the bacterial isolates belong to the same species, especially if any conclusions regarding zoonotic spread of resistance are to be made.
